161 related articles for article (PubMed ID: 7509002)
1. Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
Saito T; Taylor G; Laver WG; Kawaoka Y; Webster RG
J Virol; 1994 Mar; 68(3):1790-6. PubMed ID: 7509002
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
Air GM; Laver WG; Webster RG
J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
[TBL] [Abstract][Full Text] [Related]
3. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Koga M; Adachi E; Kikuchi T; Wang IH; Yamada S; Kawaoka Y
Nat Microbiol; 2019 Jun; 4(6):1024-1034. PubMed ID: 30886361
[TBL] [Abstract][Full Text] [Related]
4. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
[TBL] [Abstract][Full Text] [Related]
5. Steps in maturation of influenza A virus neuraminidase.
Saito T; Taylor G; Webster RG
J Virol; 1995 Aug; 69(8):5011-7. PubMed ID: 7541844
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
7. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
Nuss JM; Air GM
J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
Brown LE; Murray JM; White DO; Jackson DC
Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
[TBL] [Abstract][Full Text] [Related]
9. Antigenic structure and variation in an influenza virus N9 neuraminidase.
Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
[TBL] [Abstract][Full Text] [Related]
10. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
[TBL] [Abstract][Full Text] [Related]
11. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
Nuss JM; Whitaker PB; Air GM
Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic analysis of the N8 neuraminidase gene of influenza A viruses.
Saito T; Kawaoka Y; Webster RG
Virology; 1993 Apr; 193(2):868-76. PubMed ID: 8460490
[TBL] [Abstract][Full Text] [Related]
13. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
14. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
15. Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.
Guo Z; Wilson JR; York IA; Stevens J
J Immunol Methods; 2018 Oct; 461():23-29. PubMed ID: 30053389
[TBL] [Abstract][Full Text] [Related]
16. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.
Air GM; Els MC; Brown LE; Laver WG; Webster RG
Virology; 1985 Sep; 145(2):237-48. PubMed ID: 2411049
[TBL] [Abstract][Full Text] [Related]
17. Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
Kirkpatrick Roubidoux E; Sano K; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
J Virol; 2022 May; 96(9):e0033222. PubMed ID: 35446141
[TBL] [Abstract][Full Text] [Related]
18. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide and deduced amino acid sequence of the influenza neuraminidase genes of two equine serotypes.
Dale B; Brown R; Miller J; White RT; Air GM; Cordell B
Virology; 1986 Dec; 155(2):460-8. PubMed ID: 3788060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
